Daynna Wolff to Humans
This is a "connection" page, showing publications Daynna Wolff has written about Humans.
Connection Strength
0.504
-
Novel high-risk acute myeloid leukemia subgroup with ERG amplification and Biallelic loss of TP53. Cancer Genet. 2023 04; 272-273:23-28.
Score: 0.033
-
Clinical utility of chromosomal microarray in establishing clonality and high risk features in patients with Richter transformation. Cancer Genet. 2022 01; 260-261:18-22.
Score: 0.030
-
Integrated genomic analysis using chromosomal microarray, fluorescence in situ hybridization and mate pair analyses: Characterization of a cryptic t(9;22)(p24.1;q11.2)/BCR-JAK2 in myeloid/lymphoid neoplasm with eosinophilia. Cancer Genet. 2020 08; 246-247:44-47.
Score: 0.028
-
Assessing Genomic Copy Number Alterations as Best Practice for Renal Cell Neoplasia: An Evidence-Based Review from the Cancer Genomics Consortium Workgroup. Cancer Genet. 2020 06; 244:40-54.
Score: 0.027
-
Whole-Genome Single Nucleotide Polymorphism Microarray for Copy Number and Loss of Heterozygosity Analysis in Tumors. Methods Mol Biol. 2019; 1908:89-111.
Score: 0.025
-
Clinical utility of concurrent single-nucleotide polymorphism microarray on fresh tissue as a supplementary test in the diagnosis of renal epithelial neoplasms. Am J Clin Pathol. 2015 Nov; 144(5):731-7.
Score: 0.020
-
A multicenter, cross-platform clinical validation study of cancer cytogenomic arrays. Cancer Genet. 2015 Nov; 208(11):525-36.
Score: 0.020
-
Clonal diversity analysis using SNP microarray: a new prognostic tool for chronic lymphocytic leukemia. Cancer Genet. 2011 Dec; 204(12):654-65.
Score: 0.015
-
Mitochondrial disorders of DNA polymerase ? dysfunction: from anatomic to molecular pathology diagnosis. Arch Pathol Lab Med. 2011 Jul; 135(7):925-34.
Score: 0.015
-
Laboratory guideline for Turner syndrome. Genet Med. 2010 Jan; 12(1):52-5.
Score: 0.013
-
Multi-Site PCR-based CMV viral load assessment-assays demonstrate linearity and precision, but lack numeric standardization: a report of the association for molecular pathology. J Mol Diagn. 2009 Mar; 11(2):87-92.
Score: 0.013
-
Guidance for fluorescence in situ hybridization testing in hematologic disorders. J Mol Diagn. 2007 Apr; 9(2):134-43.
Score: 0.011
-
Jumping translocation of 1q in BCR/ABL-positive acute lymphoblastic leukemia. Cancer Genet Cytogenet. 2007 Jan 01; 172(1):90-1.
Score: 0.011
-
HER2 testing: a review of detection methodologies and their clinical performance. Expert Rev Mol Diagn. 2007 Jan; 7(1):53-64.
Score: 0.011
-
The genetics of bladder cancer: a cytogeneticist's perspective. Cytogenet Genome Res. 2007; 118(2-4):177-81.
Score: 0.011
-
Pediatric T-cell acute lymphoblastic leukemia with aberrations of both MLL loci. Cancer Genet Cytogenet. 2006 Jul 01; 168(1):77-9.
Score: 0.010
-
Detection of an apparent homozygous 3120G>A cystic fibrosis mutation on a routine carrier screen. J Mol Diagn. 2006 Feb; 8(1):137-40.
Score: 0.010
-
Fluorescence in situ hybridization for detecting transitional cell carcinoma: implications for clinical practice. BJU Int. 2005 Dec; 96(9):1280-5.
Score: 0.010
-
Developing a sustainable process to provide quality control materials for genetic testing. Genet Med. 2005 Oct; 7(8):534-49.
Score: 0.010
-
Section E6 of the ACMG technical standards and guidelines: chromosome studies for acquired abnormalities. Genet Med. 2005 Sep; 7(7):509-13.
Score: 0.010
-
A case of infantile acute myelogenous leukemia with MLL-MLL10 fusion caused by insertion of 11q into 10p. Cancer Genet Cytogenet. 2005 Jun; 159(2):181-3.
Score: 0.010
-
Neuropathologic Findings in Galloway-Mowat Syndrome 3 With a Novel OSGEP Variant. J Neuropathol Exp Neurol. 2022 Oct 18; 81(11):947-949.
Score: 0.008
-
Apparent coexistence of ETV6::RUNX1 and KMT2A::MLLT3 fusions due to a nonproductive KMT2A rearrangement in B-ALL. Leuk Lymphoma. 2022 09; 63(9):2243-2246.
Score: 0.008
-
Chromosomal microarray analysis, including constitutional and neoplastic disease applications, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021 10; 23(10):1818-1829.
Score: 0.007
-
Establishment and genomic characterization of a sporadic malignant peripheral nerve sheath tumor cell line. Sci Rep. 2021 03 11; 11(1):5690.
Score: 0.007
-
Cryptic and atypical KMT2A-USP2 and KMT2A-USP8 rearrangements identified by mate pair sequencing in infant and childhood leukemia. Genes Chromosomes Cancer. 2020 07; 59(7):422-427.
Score: 0.007
-
Technical laboratory standards for interpretation and reporting of acquired copy-number abnormalities and copy-neutral loss of heterozygosity in neoplastic disorders: a joint consensus recommendation from the American College of Medical Genetics and Genomics (ACMG) and the Cancer Genomics Consortium (CGC). Genet Med. 2019 09; 21(9):1903-1916.
Score: 0.006
-
A high prevalence of biallelic RPE65 mutations in Costa Rican children with Leber congenital amaurosis and early-onset retinal dystrophy. Ophthalmic Genet. 2019 04; 40(2):110-117.
Score: 0.006
-
Expression of renal cell markers and detection of 3p loss links endolymphatic sac tumor to renal cell carcinoma and warrants careful evaluation to avoid diagnostic pitfalls. Acta Neuropathol Commun. 2018 10 19; 6(1):107.
Score: 0.006
-
Assessing copy number aberrations and copy-neutral loss-of-heterozygosity across the genome as best practice: An evidence-based review from the Cancer Genomics Consortium (CGC) working group for chronic lymphocytic leukemia. Cancer Genet. 2018 12; 228-229:236-250.
Score: 0.006
-
Authors' Reply. J Mol Diagn. 2018 01; 20(1):125-126.
Score: 0.006
-
First Report of Prenatal Ascertainment of a Fetus With Homozygous Loss of the SOX10 Gene and Phenotypic Correlation by Autopsy Examination. Pediatr Dev Pathol. 2018 Nov-Dec; 21(6):561-567.
Score: 0.006
-
Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. J Mol Diagn. 2017 01; 19(1):4-23.
Score: 0.005
-
Urothelial carcinoma of donor origin in a kidney transplant patient. J Immunother Cancer. 2016; 4:63.
Score: 0.005
-
Chromothripsis in Two Patients With Renal Cell Carcinoma: A Case Series. Clin Genitourin Cancer. 2017 02; 15(1):e137-e143.
Score: 0.005
-
Pathogenetics of alveolar capillary dysplasia with misalignment of pulmonary veins. Hum Genet. 2016 May; 135(5):569-586.
Score: 0.005
-
Comparison Between HER2, Estrogen Receptors and Progesterone Receptors in Primary Breast Carcinomas and Matched Lymph Node Metastases. Turk Patoloji Derg. 2016; 32(3):178-85.
Score: 0.005
-
"Low-Fat" Pseudoangiomatous Spindle Cell Lipoma: A Rare Variant With Loss of 13q14 Region. Am J Dermatopathol. 2015 Dec; 37(12):920-3.
Score: 0.005
-
Clinical investigational studies for validation of a next-generation sequencing in vitro diagnostic device for cystic fibrosis testing. Expert Rev Mol Diagn. 2014 Jun; 14(5):605-22.
Score: 0.005
-
Evaluation of urovysion and cytology for bladder cancer detection: a study of 1835 paired urine samples with clinical and histologic correlation. Cancer Cytopathol. 2013 Oct; 121(10):591-7.
Score: 0.004
-
American College of Medical Genetics and Genomics technical standards and guidelines: microarray analysis for chromosome abnormalities in neoplastic disorders. Genet Med. 2013 Jun; 15(6):484-94.
Score: 0.004
-
Association of age with fluorescence in situ hybridization abnormalities in multiple myeloma reveals higher rate of IGH translocations among older patients. Leuk Lymphoma. 2012 Dec; 53(12):2444-8.
Score: 0.004
-
Validation of fluorescence in situ hybridization using an analyte-specific reagent for detection of abnormalities involving the mixed lineage leukemia gene. Arch Pathol Lab Med. 2012 Jan; 136(1):47-52.
Score: 0.004
-
College of American Pathologists/American College of Medical Genetics proficiency testing for constitutional cytogenomic microarray analysis. Genet Med. 2011 Sep; 13(9):765-9.
Score: 0.004
-
American College of Medical Genetics recommendations for the design and performance expectations for clinical genomic copy number microarrays intended for use in the postnatal setting for detection of constitutional abnormalities. Genet Med. 2011 Jul; 13(7):676-9.
Score: 0.004
-
The utility of fluorescence in situ hybridization (FISH) analysis in diagnosing graft versus host disease following orthotopic liver transplant. Ann Clin Lab Sci. 2011; 41(2):188-92.
Score: 0.004
-
Tetraploidy and 5q deletion in myelodysplastic syndrome: a case report. Cancer Genet Cytogenet. 2008 May; 183(1):64-8.
Score: 0.003
-
Altered promoter usage characterizes monoallelic transcription arising with ERBB2 amplification in human breast cancers. Genes Chromosomes Cancer. 2006 Nov; 45(11):983-94.
Score: 0.003
-
Cytogenetic heteromorphisms: survey results and reporting practices of giemsa-band regions that we have pondered for years. Arch Pathol Lab Med. 2006 Jul; 130(7):947-9.
Score: 0.003
-
HER-2 fluorescence in situ hybridization: results from the survey program of the College of American Pathologists. Arch Pathol Lab Med. 2006 Mar; 130(3):325-31.
Score: 0.003
-
Abnormal fluorescence in situ hybridization analysis in collecting duct carcinoma. Urology. 2005 Nov; 66(5):1110.
Score: 0.002
-
Technical standards and guidelines: venous thromboembolism (Factor V Leiden and prothrombin 20210G >A testing): a disease-specific supplement to the standards and guidelines for clinical genetics laboratories. Genet Med. 2005 Jul-Aug; 7(6):444-53.
Score: 0.002
-
HER-2/neu amplified breast cancers in South Carolina. J S C Med Assoc. 2005 Apr; 101(4):97-9.
Score: 0.002
-
Mosaic duplication 1(q11q44) in an infant with nephroblastomatosis and mineralization of extraplacental membranes. Pediatr Dev Pathol. 2005 Jan-Feb; 8(1):115-23.
Score: 0.002
-
Multicenter characterization and validation of the intron-8 poly(T) tract (IVS8-T) status in 25 Coriell cell repository cystic fibrosis reference cell lines for cystic fibrosis transmembrane conductance regulator (CFTR) gene mutation assays. Clin Chem. 2004 Jan; 50(1):251-4.
Score: 0.002
-
Clinical, genetic, and biophysical characterization of a homozygous HERG mutation causing severe neonatal long QT syndrome. Pediatr Res. 2003 May; 53(5):744-8.
Score: 0.002